India's cheap weight-loss drugs could reshape global obesity fight

Date:

March 18, 2026

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Previous article

चिता के कोयले से होटल-रेस्टोरेंट्स में जल रही भटि्टयां:श्मशान के कोयले से बन रही अगरबत्ती; पूरा नेटवर्क होगा एक्सपोज, कल से देखिए 'ऑपरेशन कोयला'

Next article

Sai Parenterals fixes price band of Rs 372-392 per share for IPO opening March 24 | India News

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

Share post:

Subscribe

spot_img

spot_img

Popular

More like this
Related